Report Detail

Pharma & Healthcare Global PET Radiopharmaceuticals Market Professional Survey Report 2019

  • RnM2778920
  • |
  • 21 January, 2019
  • |
  • Global
  • |
  • 105 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global PET Radiopharmaceuticals market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on PET Radiopharmaceuticals volume and value at global level, regional level and company level. From a global perspective, this report represents overall PET Radiopharmaceuticals market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of PET Radiopharmaceuticals in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their PET Radiopharmaceuticals manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
F-18
Ru-82
Others

Segment by Application
Oncology
Cardiology
Neurology
Others


Table of Contents

    Executive Summary

      1 Industry Overview of PET Radiopharmaceuticals

      • 1.1 Definition of PET Radiopharmaceuticals
      • 1.2 PET Radiopharmaceuticals Segment by Type
        • 1.2.1 Global PET Radiopharmaceuticals Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 F-18
        • 1.2.3 Ru-82
        • 1.2.4 Others
      • 1.3 PET Radiopharmaceuticals Segment by Applications
        • 1.3.1 Global PET Radiopharmaceuticals Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Oncology
        • 1.3.3 Cardiology
        • 1.3.4 Neurology
        • 1.3.5 Others
      • 1.4 Global PET Radiopharmaceuticals Overall Market
        • 1.4.1 Global PET Radiopharmaceuticals Revenue (2014-2025)
        • 1.4.2 Global PET Radiopharmaceuticals Production (2014-2025)
        • 1.4.3 North America PET Radiopharmaceuticals Status and Prospect (2014-2025)
        • 1.4.4 Europe PET Radiopharmaceuticals Status and Prospect (2014-2025)
        • 1.4.5 China PET Radiopharmaceuticals Status and Prospect (2014-2025)
        • 1.4.6 Japan PET Radiopharmaceuticals Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia PET Radiopharmaceuticals Status and Prospect (2014-2025)
        • 1.4.8 India PET Radiopharmaceuticals Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of PET Radiopharmaceuticals
      • 2.3 Manufacturing Process Analysis of PET Radiopharmaceuticals
      • 2.4 Industry Chain Structure of PET Radiopharmaceuticals

      3 Development and Manufacturing Plants Analysis of PET Radiopharmaceuticals

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global PET Radiopharmaceuticals Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of PET Radiopharmaceuticals
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 PET Radiopharmaceuticals Production and Capacity Analysis
      • 4.2 PET Radiopharmaceuticals Revenue Analysis
      • 4.3 PET Radiopharmaceuticals Price Analysis
      • 4.4 Market Concentration Degree

      5 PET Radiopharmaceuticals Regional Market Analysis

      • 5.1 PET Radiopharmaceuticals Production by Regions
        • 5.1.1 Global PET Radiopharmaceuticals Production by Regions
        • 5.1.2 Global PET Radiopharmaceuticals Revenue by Regions
      • 5.2 PET Radiopharmaceuticals Consumption by Regions
      • 5.3 North America PET Radiopharmaceuticals Market Analysis
        • 5.3.1 North America PET Radiopharmaceuticals Production
        • 5.3.2 North America PET Radiopharmaceuticals Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America PET Radiopharmaceuticals Import and Export
      • 5.4 Europe PET Radiopharmaceuticals Market Analysis
        • 5.4.1 Europe PET Radiopharmaceuticals Production
        • 5.4.2 Europe PET Radiopharmaceuticals Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe PET Radiopharmaceuticals Import and Export
      • 5.5 China PET Radiopharmaceuticals Market Analysis
        • 5.5.1 China PET Radiopharmaceuticals Production
        • 5.5.2 China PET Radiopharmaceuticals Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China PET Radiopharmaceuticals Import and Export
      • 5.6 Japan PET Radiopharmaceuticals Market Analysis
        • 5.6.1 Japan PET Radiopharmaceuticals Production
        • 5.6.2 Japan PET Radiopharmaceuticals Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan PET Radiopharmaceuticals Import and Export
      • 5.7 Southeast Asia PET Radiopharmaceuticals Market Analysis
        • 5.7.1 Southeast Asia PET Radiopharmaceuticals Production
        • 5.7.2 Southeast Asia PET Radiopharmaceuticals Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia PET Radiopharmaceuticals Import and Export
      • 5.8 India PET Radiopharmaceuticals Market Analysis
        • 5.8.1 India PET Radiopharmaceuticals Production
        • 5.8.2 India PET Radiopharmaceuticals Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India PET Radiopharmaceuticals Import and Export

      6 PET Radiopharmaceuticals Segment Market Analysis (by Type)

      • 6.1 Global PET Radiopharmaceuticals Production by Type
      • 6.2 Global PET Radiopharmaceuticals Revenue by Type
      • 6.3 PET Radiopharmaceuticals Price by Type

      7 PET Radiopharmaceuticals Segment Market Analysis (by Application)

      • 7.1 Global PET Radiopharmaceuticals Consumption by Application
      • 7.2 Global PET Radiopharmaceuticals Consumption Market Share by Application (2014-2019)

      8 PET Radiopharmaceuticals Major Manufacturers Analysis

      • 8.1 Cardinal Health Inc. (U.S.)
        • 8.1.1 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production Sites and Area Served
        • 8.1.2 Cardinal Health Inc. (U.S.) Product Introduction, Application and Specification
        • 8.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Mallinckrodt plc (Ireland)
        • 8.2.1 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production Sites and Area Served
        • 8.2.2 Mallinckrodt plc (Ireland) Product Introduction, Application and Specification
        • 8.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 GE Healthcare (U.K.)
        • 8.3.1 GE Healthcare (U.K.) PET Radiopharmaceuticals Production Sites and Area Served
        • 8.3.2 GE Healthcare (U.K.) Product Introduction, Application and Specification
        • 8.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Lantheus Medical Imaging, Inc. (U.S.)
        • 8.4.1 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production Sites and Area Served
        • 8.4.2 Lantheus Medical Imaging, Inc. (U.S.) Product Introduction, Application and Specification
        • 8.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Bayer AG (Germany)
        • 8.5.1 Bayer AG (Germany) PET Radiopharmaceuticals Production Sites and Area Served
        • 8.5.2 Bayer AG (Germany) Product Introduction, Application and Specification
        • 8.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Bracco Imaging S.p.A (Italy)
        • 8.6.1 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production Sites and Area Served
        • 8.6.2 Bracco Imaging S.p.A (Italy) Product Introduction, Application and Specification
        • 8.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Eczacibasi-Monrol Nuclear Products (Turkey)
        • 8.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production Sites and Area Served
        • 8.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Product Introduction, Application and Specification
        • 8.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Nordion, Inc. (Canada)
        • 8.8.1 Nordion, Inc. (Canada) PET Radiopharmaceuticals Production Sites and Area Served
        • 8.8.2 Nordion, Inc. (Canada) Product Introduction, Application and Specification
        • 8.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Advanced Accelerator Applications S.A. (France)
        • 8.9.1 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production Sites and Area Served
        • 8.9.2 Advanced Accelerator Applications S.A. (France) Product Introduction, Application and Specification
        • 8.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 IBA Molecular Imaging (Belgium)
        • 8.10.1 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production Sites and Area Served
        • 8.10.2 IBA Molecular Imaging (Belgium) Product Introduction, Application and Specification
        • 8.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of PET Radiopharmaceuticals Market

      • 9.1 Global PET Radiopharmaceuticals Market Trend Analysis
        • 9.1.1 Global PET Radiopharmaceuticals Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 PET Radiopharmaceuticals Regional Market Trend
        • 9.2.1 North America PET Radiopharmaceuticals Forecast 2019-2025
        • 9.2.2 Europe PET Radiopharmaceuticals Forecast 2019-2025
        • 9.2.3 China PET Radiopharmaceuticals Forecast 2019-2025
        • 9.2.4 Japan PET Radiopharmaceuticals Forecast 2019-2025
        • 9.2.5 Southeast Asia PET Radiopharmaceuticals Forecast 2019-2025
        • 9.2.6 India PET Radiopharmaceuticals Forecast 2019-2025
      • 9.3 PET Radiopharmaceuticals Market Trend (Product Type)
      • 9.4 PET Radiopharmaceuticals Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 PET Radiopharmaceuticals Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on PET Radiopharmaceuticals . Industry analysis & Market Report on PET Radiopharmaceuticals is a syndicated market report, published as Global PET Radiopharmaceuticals Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of PET Radiopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,772.00
        4,158.00
        5,544.00
        3,241.00
        4,861.50
        6,482.00
        529,725.00
        794,587.50
        1,059,450.00
        291,900.00
        437,850.00
        583,800.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report